N/A
N=6,274
Comparing Types of Implementation of a Shared Decision Making Intervention
Asthma
Bottom Line
View on ClinicalTrials.gov: NCT02047929 ↗Enrolled (actual)
6,274
Serious AEs
—
Results posted
Jun 2019
Primary outcome: Primary: Patient Perception of Shared Decision Making — 34; 40; 86; 79 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Asthma Shared Decision Making (SDM) Toolkit (Other)
- Age
- Pediatric, Adult, Older Adult · 1+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Aug 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Perception of Shared Decision Making |
34; 40; 86; 79; 528; 347 | — |
| SECONDARY Health Outcomes |
144; 355; 288; 23; 29; 38 | — |
| SECONDARY Medication Adherence |
— | — |
Summary
Asthma is a common disease that affects people of all ages and has significant morbidity and mortality. Poor outcomes and health disparities related to asthma result in part from the difficulty of disseminating new evidence and paradigms of care delivery such as shared decision making (SDM) into clinical practice. This study will evaluate a novel mechanism for dissemination of an evidence-based SDM Toolkit for asthma care in primary care practices. The study is ideally suited to study dissemination methods because it will leverage a partnership between an established consortium of practice based research networks (PBRNs) and an advanced Medicaid Network.
This study will evaluate a novel dissemination process (FLOW) to spread an Asthma Shared Decision Making Toolkit to practices within a Medicaid network using a consortium of practice-based research networks (NCNC). The knowledge gained from this proposal and the partnerships formed between practice-based research networks and NC Medicaid will facilitate widespread dissemination to almost 300 practices.
Eligibility Criteria
Inclusion Criteria: North Carolina practices will be eligible for participation in the study if they have over 75 active Medicaid patients in their panel with the diagnosis of asthma.
-
Exclusion Criteria: Prior participation in the Asthma Comparative Effectiveness Study.
-
Data sourced from ClinicalTrials.gov (NCT02047929). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.